Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham

Size: px
Start display at page:

Download "Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham"

Transcription

1 Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham

2 A Case of Inpatient Diabetes Mrs DE Ketosis-prone T2DM on bd Humulin-I, Metformin and Linagliptin Admitted with a fall 19:00h nursing note - patient declined most of her evening meal :00h Dr called to review CBG 1.1 mmol/l FY1 note given IM Glucagon, ½ Glucogel and 100mL 10% Glucose - CBG 13.0 mmol/l Stop IV Glucose and monitor CBG hourly :00h JD WR Events overnight noted very low BGs, BGs and. Having frequent hypos. Earlier in the week agreed to sheltered accommodation. No recollection of this. Plan reduce Humulin-I by 4 units Speak to Diabetes consultant Arrange best interest meeting

3 :30h Nursing note - CBG 3.0 mmol/l A Case of Inpatient Diabetes Given Glucogel, cup of tea and 2 biscuits Recheck CBG 5.0 mmol/l :00h JD WR Applying for guardianship BGs high on admission may have not been taking Metformin and Linagliptin HbA1c between % since 2013 Note severe hypo on Not had insulin since the HbA1c (%) eag (mmol/l) Plan stop insulin, PRN Novorapid if required, target HbA1c 9-10% comfortably as all we need to do is limit hyperosmolar symptoms and stop dangerous hypos.

4

5 A Case of Inpatient Diabetes :10h Nursing note - BGs Hi, ketones 6.0 mmol/l SHO advice 4 units Novorapid 13:30h BGs - Hi, ketones 5.5 mmol/l 16:00h FY2 review Repeat ketones now 2.6 mmol/l Patient had been drinking Lucozade which caused the spike Plan due to receive Metformin Repeat CBG at 1830h Give 5 units Novorapid for one off high BGs Ketones though high responded to Novorapid and with her present state and non-compliance I see it not with starting on sliding scale 22:00h FY1 review Currently BG unrecordable and ketones 1.7 mmol/l Plan repeat Novorapid 4 units and recheck ketones, please contact if >0.6 mmol/l

6 A Case of Inpatient Diabetes (continued) Consultant WR CBGs was 33 over the weekend. Had 3 bottles of Lucozade. CBG coming down. Patients looks well. Plan await court of protection and continue current treatment of Novomix (meant Novorapid) :00h DADOT review AMT4 = 0, Attention obviously altered, very drowsy but rousable. Acute event is evident 4AT = 8, Delirium is evident :15h Nursing note Appears to be getting more confused BGs 33.1 mmol/l and ketones 7.1 mmol/l Dr informed Actrapid 4 units given For IV sliding scale 14:00h CT1 note Patient vomiting O/E MEWS = 2 and mild epigastric tenderness Imp DKA

7

8 Mrs DE Glycaemic Control during her Admission

9 Does Glycaemic Control Matter? Hyperglycaemia is important

10

11

12

13 Does Glycaemic Control Matter? Hypoglycaemia is important

14

15 Summary of hypothetical relationship(s) between hyperglycaemia and adverse outcomes in patients with ACS and posited mechanisms of the beneficial effects of insulin. Intravenous Insulin Christina H. Wei, and Sheldon E. Litwin Diabetes 2014;63:

16 Update on Mrs DE Admitted 6 weeks later with AMI

17 What should the inpatient blood glucose target be?

18

19 Insulin Secretion The Basal Bolus Concept Insulin Component Basal Bolus Properties Near-constant insulin level throughout the day Suppresses hepatic glucose production (glycogenolysis and gluconeogesis), proteolysis and lipolysis. Insulin requirement to suppress hepatic glucose production overnight and between meals. Covers ~50% of the total daily insulin requirement Reflects BG overnight, before breakfast and before meals if there is a 5- hour gap. Immediate rise and sharp peak at 1-hour Limits post-meal hyperglycemia Insulin requirement to maintain normal glucose disposal after eating Cover ~50% of the total daily insulin requirement (10-20% at each meal) Reflects BG 2-hours after meals

20

21 Bolus/prandial insulin is necessary for maintaining blood glucose control, after food (prevents post prandial hyperglycaemia). Therefore basal insulin is continuous insulin secreted between meals and bolus/prandial insulin is secreted in burst in response to eating. How would we manage without basal insulin? Because the liver is secreting glucose into the bloodstream continuously, a complete lack of insulin, would result in a sharp rise in blood glucose level (2.5 mmol/l/h). Without basal insulin, cells would resort to burning only fat for energy, and produce ketones. Continuous insulin = basal insulin and switches off ketogenesis and ensures cells get energy between meals. How would we manage without bolus/prandial insulin? Without bolus/prandial insulin, we are unable to control post prandial glucose.

22 Insulin Requirement When Unwell

23 Insulin Regimes for Hospital TYPE OF INSULIN Name What is it Indications Starting TDD Dose BACKGROUND/BASAL INSULIN Glargine (Lantus) Levemir (Detemir) Insulatard or Humulin-I Consists of a long-acting insulin preparation administered regardless of the patient s oral intake status, with the premise of matching hepatic (endogenous) glucose production Not controlled on oral multiple anti-diabetic agents. Course of treatment for specific indication e.g. starting steroids, oral antidiabetic agents suspended. 0.3 units/kg E.g. 80 kg = 0.3 x 80 = 24 units. PRANDIAL/BOLUS INSULIN BASAL BOLUS REGIME PRE-MIXED TWICE DAILY INSULIN Novorapid Combination of basal Novomix 30 Humalog insulin and rapid acting Humalog Mix 50 Glulisine analogue insulin. Humalog Mix 25 Rapid-acting Long-acting basal insulin Pre-mixed analogue insulin administered regardless combination of preparation given to of the patient s oral intermediate acting cover nutritional intake status and rapidacting and rapid acting needs. analogue insulin analogue insulin. preparation given to cover nutritional needs. In combination with basal insulin e.g. basal plus or basal bolus. 0.1 units/kg E.g. 80 kg = 0.1 x 80 = 8 units For tight glycaemic control and flexible regime. 0.5 units/kg E.g. 80 kg = 0.5 x 80 = 40 units. Basal = 50% Bolus =50% Basal = 20 units Bolus = 7 units tds Poor glycaemic control on anti-diabetic agents or basal insulin only not wanting four injections. 0.5 units/kg E.g. 80 kg = 0.5 x 80 = 40 units SUPPLEMENTAL OR CORRECTION INSULIN Novorapid Humalog Glulisine Rapid-acting analogue insulin To correct capillary blood glucose (CBGs) values that exceed predetermined targets. T1DM 1 unit to lower CBG by 2.0 mmol/l T2DM 0.1 unit/kg Consider lower dose in frail elderly, CKD stage 4/5 e.g. 0.2 units/kg for basal insulin and higher doses in obese, on steroids or HbA1c >9.0% (75 mmol/mol) e.g. 0.6 units/kg for pre-mixed insulin.

24 Insulin Regimes for Hospital TYPE OF INSULIN BACKGROUND/BASAL INSULIN PRANDIAL/BOLUS INSULIN BASAL BOLUS REGIME PRE-MIXED TWICE DAILY INSULIN SUPPLEMENTAL OR CORRECTION INSULIN Do you continue when not eating What percentage of the TDD to give when not eating What do when unwell Monitoring required to adjust insulin dose Yes, may require a reduced dose No, as patient is not eating Yes, but at 50% of the TDD OR convert to basal insulin only at 50% of their TDD 100% of the TDD None 100% of the basal 50% Variable Basal insulin requirement may remain constant or often increase. Pre-breakfast (fasting) and pre-evening meal CBG. Depending on whether the patient is eating or not the bolus insulin requirement may increase or decrease 2-hours post meal BG Same as for basal and prandial insulin. Pre-mixed doses may need to increase Pre-breakfast (fasting) and pre-evening meal BG.. Used only to correct CBGs which are above target. Correction doses of insulin may be required to maintain good glycaemic control. If repeated correction doses are required the current regime should be reviewed, probably requiring an increase. Variable

25 Commence New Antidiabetic Medication. When CBG<12.0mmol/L start: 1. Basal Bolus Insulin for T1DM or ketosis prone T2DM - Total daily dose (TDD) units/kg 2. Basal Only Insulinfor T2DMs on 3 different tablets or 1 or 2 tablets and CBG 14.0mmol/L. - TDD units/kg. Continue all the tablets. 3. Premixed Additional Twice new daily class Insulin of antidiabetic 0.5 units/kg. tablet Continue if 1 Metformin 2 tablets stop and all CBG<14.0 other tablets. mmol/l(page 1.) Basal Bolus Regime Rapid acting insulinse.g.humalog or Novorapid Long acting Insulinse.g. Lantus orlevemir For Basal Only Regime Long acting Insulinse.g.Lantus, Levemir or Insulatard Starting Insulin Give 50% of total dose with evening meal in the form of long acting insulin and divide the remaining dose equally with meals for rapid acting insulin Meal Breakfast Lunch Evening Bedtime Rapid acting 6 units 6units 6 units Long acting 18 units Give 50% of total dose with evening meal in the form of long acting insulin and divide the remaining dose equally with meals for rapid acting insulin Meal Breakfast Lunch Evening Bedtime Lantus 22units Levemir 22 units Insulatard 11 units 11 units E.g. Weight 72 Kg, starting total daily dose (TDD) 0.5 x 72 = 36 units. E.g. Weight 72 Kg, starting total daily dose (TDD) 0.3 x 72 = 22 units. NOTE: Pre-mixed BASAL Insulin INSULIN MUST BE GIVEN MealPRIOR TO Breakfast DISCHARGE OTHERWISE Lunch AFTER 4 HOURS Evening THE PATIENT Bedtime WILL NOT HAVE ANY INSULIN ON BOARD AS THE RAPID ACTING INSULIN WOULD HAVE RUN OUT. Novomix 30/Humalog 24 units 12 units Mix 25/Humalog Mix 25 CRITERIA FOR DISCHARGE All are necessary for a safe discharge 1. Able to monitor& record CBG independently 5. Capillary Ketones <0.6 mmol/l 2. Able to administer insulin independently 6.CBG 10.0 mmol/l 3. Access to a telephone Able to attend a follow up appointment in the Diabetes Centre x42034 Fax E.g. Weight 72kg, starting TDD 0.5 x 72 = 36 units

26 What to do if the patient is not eating? Mrs A is a type 1 diabetic on a basal bolus regime Breakfast Lunch Evening Meal Bed Humalog Glargine 30 He presents with symptoms consist with pyelonephritis fever, loin pain, dysuria and a urine dipstick positive for leucocytes and nitrites. Investigations - WCC 24.7, CRP 212 and CBG 8.4 mmol/l. He is feeling nauseous and does not feel like eating What do you do to control his BG? Answer - Continue Glargine and suspend Humalog while not eating Breakfast Lunch Evening Meal Bed Humalog Glargine 30 Mr C is a type 2 diabetic on a premixed bd insulin regime Breakfast Lunch Evening Meal Bed Novomix He presents with diarrhoea. He is fluid resuscitated and started on replacement and with 0.9% NaCl with KCl. CBG is 6.4 mmol/l and capillary ketones 0.1. He does not feel like eating What should be done with his insulin regime to control his BG? Continue current regime at 50% of the usual dose Breakfast Lunch Evening Meal Bed Novomix

27 How to give a Correction Dose

28 How to Calculate the dose and When to Recheck CBG? Type 1 Diabetes* Assume that 1 unit will drop capillary blood glucose (CBG) by 2.0 mmol/l, to a maximum dose of 10 units initially. Aim to correct to 8.0 mmol/l E.g. if CBG was 28.0 mmol/l, = 20.0, = 10, therefore give 10 units. Type 2 Diabetes* Give 0.1 units/kg of insulin to a maximum dose of 10 units initially. Example 100 kg patient = 100 x 0.1 = 10 units *Wherever possible take advice from the patient about the amount of insulin normally required to correct a high blood glucose (Correction or Insulin Sensitivity Factor) 1st check - 2-hours At peak effect. Is it coming down? 2 nd check - 4-hours Glucose lowering effect almost complete. Decision on further Rx reqd

29 How to Manage Inpatient Diabetes and Hyperglycaemia

30 Now for some cases!!

31 Case 1 Self referral to ED. 54 year old Asian male with T2DM. Presented with hyperglycaemia. On examination she was afebrile, pulse 82 regular, BP 134/76, RS clinically clear, weight 85 kg. Current Regime Breakfast Lunch Evening meal Bedtime Metformin 1g 1g Gliclazide 80mg 80mg Sitagliptin 100mg The laboratory data showed: Na+ 138 mmol/l ( ) WCC 5.4 ( ) K+ 4.9 mmol/l ( ) Hb 155 ( ) Urea 8.6 mmol/l ( ) Plts 300 ( ) Cr 88 mmol/l (60 110) CRP 12 (<10mg/dL) Capillary blood glucose 18.4 mmol/l Capillary ketones 0.4 mmol/l (<0.6) HbA1c 9.4% (79 mmol/mol) What is the diagnosis? Hyperglycaemia

32 How would you manage Case 1? 1. Correction dose of rapid acting insulin such as Humalog. 0.1 unit/kg 85 x 0.1 = 8.5, therefore give 8.0 units 2. Start basal insulin - Humulin-I 0.3 units/kg = 0.8 x 85 = 25.5, therefore 26 units Breakfast Lunch Evening meal Bedtime Humulin-I 13 units 13 units 3. Recheck CBG and ketones in 2 hours - If CBG <12.0 mmol/l and capillary ketones < 0.6 mmol/l, the patient can be discharged. - If CBG >12.0 mmol/l give a 2 nd correction dose and repeat CBG and capillary ketones in 2 hours. Criteria for discharge, same as above. 4. Give ml of Hartmanns over 2 hours to correct the dehydration and help lower CBG 5. Continue all their other oral anti-diabetic medications 6. Contact Inpatient Diabetes Team to organise education on insulin administration, CBG monitoring and the treatment of hypoglycaemia.

33 Case 2 A 19-year-old single diabetic Caucasian woman had been on 22 units of Lantus and 8 units of Novorapid before meals daily for six years. She presented at the ED with nausea and malaise of a 1 day duration. Polyuria, polydipsia and altered CBG values had been present for approximately one month, but were overlooked by the patient. The laboratory data showed: Na+ 134 mmol/l ( ) K+ 4.7 mmol/l ( ) Urea 7.2 mmol/l ( ) Cr 72 mmol/l (60 110) Capillary blood glucose 22.4mmol/L Capillary ketones 2.1 mmol/l (<0.6) Venous Gas ph 7.35 ( ) HCO (24-28) K+ 4.7 ( ) Cl 104 (95-105) Lactate 0.9 mmol/l ( ) Anion gap 8 (8-12) What is the diagnosis?

34 Management of Mild DKA with Subcutaneous Rapid Acting Insulin Management of DKA with Subcutaneous Rapid Acting Insulin Indications - Patients with mild ketosis and acidosis Criteria -Type 1 or Type 2 Diabetes - CBG >14.0 mmol/l - capillary ketones mmol/l - ph 7.25 Type of Insulins to be used Novorapid/Humalog/Glulisine Resolution of ketosis = capillary ketones <0.6 mmol/l Resolution of hyperglycaemia = CBG <12.0 mmol/l If not confident treat as DKA Intravenous Fluids Potassium Replacement Insulin Therapy Subcutaneous Insulin 2 hourly Laboratory % sodium chloride (NaCl) at 500-1,000ml/h for 2 h 1. If serum K + 5.5mmol/L, do not give K,, but check serum K every 2 h a) Initial dose SC: units/kg OR 1 unit to lower CBG by 2.0 units followed by Admission: FBC, U&Es, Glc, venous gas for ph and bicarbonate and K % NaCl at ml/h until blood glucose 14.0mmol/L 2. If K mmol/l, add 20 mmol of KCl to each litre of IV fluid b) SC rapid-acting insulin at units 2 hours later and then Capillary Glucose: Check glucose every hour 3. When blood glucose <14.0mmol/L use NaCl 0.18%, Glucose 4% at ml/h until resolution of ketosis 3. If K mmol/L, add 40 mmol of KCl to each litre of IV fluid c) SC insulin unist/kg every 2 hours to keep glucose at 12.0mmol/L until resolution of ketosis. Capillary Ketones (bhydroxybutyrate): Check ketones every hour 4. If K + <3.0 mmol/l, give mmol of KCl per hour until serum K + >3.0 mmol/l, then add 40 mmol of KCl to each litre of IV fluid Venous Gas for ph and bicarbonate and K + every 2 hours

35 Case 3 A 73 year old woman with T2DM is referred to the AMU from the ED. She has been unwell with thirst, dysuria and urinary frequency for 3 days. On examination she was drowsy with a Glasgow Coma Scale of 9. Blood pressure is 104/76mmHg, pulse 126 bpm and irregular. Capillary blood glucose is reading high. The laboratory data showed: Na+ 139 mmol/l ( ) K+ 5.6 mmol/l ( ) Urea 19.2 mmol/l ( ) Cr 189 µmol/l (60 110) Serum glucose 41.1 mmol/l ( ) Arterial Blood Gas (on air) ph 7.41 ( ) po kpa ( ) pco kpa ( ) bicarbonate 22.2 mmol/l (24-28) base excess 0.8 mmol/l (±2) Calculated Serum Osmolality 2(Na + K) + Urea + Glc = Or (2Na + Glc + Urea) = Hyperosmolality >320

36 How to manage Case 3 INTRAVENOUS fluids 0.9% NaCl to correct circulatory volume and dehydration. Only switch to 0.45% NaCl if the osmolality is not declining An initial rise in Na + is expected Do Not give 0.45% NaCl. The rate of fall of Na + should not exceed 10.0 mmol/l in 24 hrs INSULIN INFUSION Start ONLY if CBG fails to fall with IV fluids Half the DKA calculated dose (0.05 unit/kg/hour) The fall in CBG should be no more than 5.0 mmol/l/hr ANTICOAGULATION Full dose anticoagulation dose unless contraindicated. DISCHARGE ANTIDIABETIC TREATMENT All patient should be discharged on INSULIN not oral agents.

37 DKA Cannula Port 1 Cannula Port 2 INTRAVENOUS 0.9% SALINE Aim/Function: 1. Fluid resuscitation and restoration of circulatory volume 2. Restore total water deficit - 100ml/kg 3. Restore total sodium deficit 7-10mmol/kg 4. Restore total potassium deficit 3-5mmol/kg Shock SBP <90mmHg, HR >100bpm, CRT >2 secs Management: 0.9% Saline aliquots 10mls/kg to max of 30mls/kg or ml aliquots Not Shocked (SBP >100mmHg) >70kg Fluid Rate (mls/h) Time (h) 0.9% Sodium chloride 1L % Sodium chloride 1L With potassium chloride* % Sodium chloride 1L With potassium chloride* % Sodium chloride 1L With potassium chloride* % Sodium chloride 1L With potassium chloride* % Sodium chloride 1L With potassium chloride* % Sodium chloride 1L With potassium chloride* Total 7 Litres 25 hours Potassium level (mmol/l) Replacement/litre fluid >5.5 Nil mmol/L < mmol/L Seek advice from specialist Assess response to treatment targets 1. CRT <2secs 2. SBP >100mmHg (MAP >70) and HR <100bpm 3. Urine output 0.5ml/kg If poor response to treatment Give fluid boluses of 0.9% Saline aliquots 10mls/kg to max of 30mls/kg or ml aliquots INTRAVENOUS INSULIN Aim/Function: 1. Resolution of ketosis 2. Correction of acidosis 3. Resolution of hyperglycaemia if present Fixed dose insulin 0.1unit/kg/hr (round up to the nearest whole number) until resolution of DKA. When CBG <12.0mmol/L Add in 5% Glucose 125mls/hr to enable fixed dose insulin to be continued. When CBG <8.0mmol/L Add in 10% Glucose 125mls/hr to enable fixed dose insulin to be continued. Resolution of DKA: Ketones<0.3mmol/L ph>7.3 Venous bicarbonate>18mmol/l CONTINUE THE 0.9% SALINE WITH THE GLUCOSE Assess response to treatment targets 1. Fall in ketones by mmol/hr 2. Rise in bicarbonate by mmol/hr 3. Fall in CBG by mmol/hr If poor response to treatment Increase insulin by 1.0unit/hr. If after 2 consecutive hours double the fixed dose to 0.2units/kg/hr CRT capillary refill time SBP systolic blood pressure MAP mean arterial pressure CBG = capillary blood glucose

38 HbA 1c HbA 1c tells you where you have arrived, but does not tell you how you got there. Capillary Blood Glucose (CBG) monitoring tells you the route you have taken. The medication used is the mode of transport.

39 Daredevil (DD) Double Digits In hospital glucose concentrations in double digits is not good for your patients 6.0 mmol/l In hospital glucose concentrations less than 6 puts your patient's at risk of falling down a slippery slope.

Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham

Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham Outline of the Talk Definitions and the burden The impact and the cost A case The effects of hyperglycaemia

More information

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission. Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:

More information

Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery

Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery Background Surgery places physical and emotional stress on the body. This, alongside new surroundings, parental anxiety and

More information

The principles of insulin adjustment guidance

The principles of insulin adjustment guidance The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according

More information

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK) Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow June 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood Glucose

More information

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK) Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow September 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood

More information

Country Health SA Local Health Network. Version control and change history

Country Health SA Local Health Network. Version control and change history Country Health SA Local Health Network Protocol (Clinical) Title: Diabetic Ketoacidosis Management in Adults with Type 1 Diabetes Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor: CHSALHN,

More information

Diabetic Ketoacidosis

Diabetic Ketoacidosis October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent

More information

Updated August /08/2020

Updated August /08/2020 Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of adults with diabetes

More information

Peri-operative management of the surgical patient with diabetes GL059

Peri-operative management of the surgical patient with diabetes GL059 DT Peri-operative management of the surgical patient with diabetes GL059 Approval Approval Group Job Title, Chair of Committee Date Anaesthetics Clinical Governance Chair Anaesthetic governance Nov 2016

More information

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION! Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours Page 1 of 2 Time of Arrival Loca8on Date / / Diagnosis the characteris8c features of a person with HHS are a) Hypovolaemia b) Marked

More information

Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group

Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group 1. Introduction 1.1 This document sets out the University Hospitals of Leicester (UHL) guidelines

More information

Staff at the Nottingham Children s Hospital. Guidelines process.

Staff at the Nottingham Children s Hospital. Guidelines  process. Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,

More information

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation CHILDREN S SERVICES Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation Background Surgery places stress on the body and will alter glucose control and insulin

More information

Use this version only

Use this version only Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS (DKA) Use this version only Patient Label Details Ward: Consultant: Named Nurse: Date of Admission: Date of Discharge/Transfer: ALL STAFF TO WRITE

More information

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date

More information

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young

More information

Country Health SA Local Health Network

Country Health SA Local Health Network Country Health SA Local Health Network Protocol (Clinical) Title: Hyperglycaemic Hyperosmolar State Management in Adults with Type 2 Diabetes Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor:

More information

Title Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.

Title Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department. Patients with Document Control Title Peri-operative Guidelines for the Management of Patients with Author Directorate Medicine Version Date Issued 0.1 Jan 2011 Status Draft Initial version Author s job

More information

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 www.diabetesvic.org.au Plan/ overview Issue/ presenting problems

More information

SCENARIO. Maternal Medicine -DKA LEARNING OBJECTIVES

SCENARIO. Maternal Medicine -DKA LEARNING OBJECTIVES SCENARIO Maternal Medicine -DKA LEARNING OBJECTIVES Recognition of the of the seriously ill patient Diagnosis of DKA in pregnancy Recognition of precipitating factors for DKA Initiate emergency management

More information

Peri-Operative Guidelines for Management of Diabetes Patients

Peri-Operative Guidelines for Management of Diabetes Patients Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering

More information

Lynda Astbury Lead Diabetes Specialist Nurse

Lynda Astbury Lead Diabetes Specialist Nurse Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)

More information

BREAK 11:10-11:

BREAK 11:10-11: 1. Sepsis Tom Heaps 09:30-10:20 2. Oncological Emergencies Clare Pollard 10:20-11:10 ------------------------ BREAK 11:10-11:30 ------------------------ 3. Diabetic Ketoacidosis Tom Heaps 11:30-12:20 4.

More information

AACN PCCN Review. Endocrine

AACN PCCN Review. Endocrine AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders

More information

MANAGEMENT OF DIABETES IN PREGNANCY

MANAGEMENT OF DIABETES IN PREGNANCY MANAGEMENT OF DIABETES IN PREGNANCY Ministry of Health Malaysia Malaysian Endocrine & Metabolic Society Perinatal Society of Malaysia Family Medicine Specialists Association of Malaysia Academy of Medicine

More information

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014 DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,

More information

St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines v24

St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines v24 St Helens & Knowsley Hospitals, 2014-16 Adult Inpatient Diabetes Management Guidelines St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines 2014-2016 v24 Title Adult Inpatient

More information

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES DEFINITION -Glucose >250 mg/dl*, anion gap > 16, + ketones * Glucose < 250 does not exclude DKA especially if anion gap >

More information

Injectable Therapies in Diabetes

Injectable Therapies in Diabetes Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Insulin therapy GLP1 antagonists Consider commonly used

More information

Injectable Therapies in Diabetes

Injectable Therapies in Diabetes Injectable Therapies in Diabetes Diabetes Specialist Nurse Linda Burns Learning Outcomes Understand the place of injectible therapies in diabetes Understand when patients may require insulin therapy Consider

More information

Information for Patients

Information for Patients Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how

More information

Diabetes, Ketone testing in Type 1 Diabetes

Diabetes, Ketone testing in Type 1 Diabetes CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised

More information

Northumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service

Northumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service Northumbria Healthcare NHS Foundation Trust Sick Day Rules for People with Diabetes Issued by the Diabetes Service www.northumbria.nhs.uk Background: How illness may affect your diabetes 3 What to do for

More information

PERIOPERATIVE DIABETES GUIDELINE

PERIOPERATIVE DIABETES GUIDELINE PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect

More information

Injectable Therapies in Diabetes

Injectable Therapies in Diabetes Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Think about when / why patients require insulin therapy

More information

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management

More information

Inpatient Diabetes 20/01/2015. What should I do? Hyperglycaemia why does it matter? Why are the BSLs unstable? BSL parameters

Inpatient Diabetes 20/01/2015. What should I do? Hyperglycaemia why does it matter? Why are the BSLs unstable? BSL parameters Hyperglycaemia why does it matter? Inpatient Diabetes Angela Sheu Endocrine Registrar St George Hospital Hyperglycaemia at admission is a predictor of mortality May be part of stress response (eg post

More information

MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY

MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY Background Management is different in different groups of women with diabetes. Women with Type 1 Diabetes (previously

More information

Guideline on Sick day rules for children and young people with diabetes on insulin

Guideline on Sick day rules for children and young people with diabetes on insulin Guideline on Sick day rules for children and young people with diabetes on insulin META DATA Title: Guidelines on Sick day rules for children and young people with Diabetes taking insulin Version: 1.0

More information

Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period

Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period Dr Ketan Dhatariya MBBS MSc MD MS FRCP Consultant in Diabetes and Endocrinology Norfolk and Norwich

More information

Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes

Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes Author: Women & Child Health Specialty: Labour Ward Forum Date Approved: March 2017 Approved by: W&CH Clinical Governance Committee

More information

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY COVER SHEET `NAME OF DOCUMENT TYPE OF DOCUMENT at Shoalhaven Hospital Group Critical Care Procedure DOCUMENT NUMBER DATE OF PUBLICATION February 2018 RISK RATING Medium REVIEW DATE February 2021 FORMER

More information

Diabetes, Type 2 Management

Diabetes, Type 2 Management CLINICAL GUIDELINE Diabetes, Type 2 Management A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the applicability

More information

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures Clinical Guidelines Management of adult patients with diabetes undergoing endoscopic s Document Detail Document type Clinical Guideline Management of adult Patients with diabetes Undergoing Document name

More information

Diabetic Ketoacidosis

Diabetic Ketoacidosis Diabetic Ketoacidosis Definition: Diabetic Ketoacidosis is one of the most serious acute complications of diabetes. It s more common in young patients with type 1 diabetes mellitus. It s usually characterized

More information

Mellitus undergoing Surgery

Mellitus undergoing Surgery Clinical Guideline Care of children Children and young under people with 18 diabetes years mellitus with Diabetes Mellitus undergoing Surgery SETTING FOR STAFF PATIENTS Insert hospital name Medical and

More information

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE DEFINITION Type 1 Diabetes: described as a total lack of insulin produced by the pancreas for the requirements of the tissues. If left untreated,

More information

Insulin Management. By Susan Henry Diabetes Specialist Nurse

Insulin Management. By Susan Henry Diabetes Specialist Nurse Insulin Management By Susan Henry Diabetes Specialist Nurse The Discovery of Insulin - 1921 - Banting & Best University Of Toronto Discovered hormone insulin in pancreatic extract of dog - Marjorie the

More information

Diabetes in the UK: Update on Diabetes Treatment and Care. Why is diabetes increasing? Obesity Increased waist circumference.

Diabetes in the UK: Update on Diabetes Treatment and Care. Why is diabetes increasing? Obesity Increased waist circumference. Update on Diabetes Treatment and Care Tahseen A Chowdhury Consultant Diabetologist Royal London and Mile End Hospitals Diabetes prevalence (thousands) Diabetes in the UK: 1995-21 3 25 2 15 1 5 Type 1 Type

More information

Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016

Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016 Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines Diabetes Inpatient Steering Group June 2016 1. Introduction 1.1 The aim of the guideline is to improve standards

More information

The York Diabetes Care Model

The York Diabetes Care Model This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin

More information

Diabetic Ketoacidosis (DKA)

Diabetic Ketoacidosis (DKA) Diabetic Ketoacidosis (DKA) Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Date of submission February

More information

A I Page 1 of 10. SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH. Clinical Protocol

A I Page 1 of 10. SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH. Clinical Protocol SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH Clinical Protocol DIABETES IN PREGNANCY Diabetes; Management of GlycaemicControl in labour and in the antenatal period. Document Information

More information

Basal Bolus Insulin Therapy Frequently Asked Questions

Basal Bolus Insulin Therapy Frequently Asked Questions 1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong

More information

Diabetes Newly Diagnosed with NO evidence of DKA

Diabetes Newly Diagnosed with NO evidence of DKA 1. DIAGNOSIS confirmed by doctor using below guidelines: (a) History of Polyuria (usually nocturia ± enuresis) Polydipsia. ± Weight Loss (b) Glycosuria (c) Blood Glucose (BG) > 11 mmol/l (confirm from

More information

FBC, HbA1c, U/E, FT4, Blood Gas, Thyroid antibodies, TSH, Coeliac screen, GAD antibodies, Islet cell antibodies, and insulin antibodies.

FBC, HbA1c, U/E, FT4, Blood Gas, Thyroid antibodies, TSH, Coeliac screen, GAD antibodies, Islet cell antibodies, and insulin antibodies. 1. DIAGNOSIS confirmed by doctor using below guidelines: (a) History of polyuria (usually nocturia ± enuresis) Polydipsia ± weight loss (b) Glycosuria (c) Blood Glucose (BG) > 11 mmol/l (confirm from a

More information

Information for all patients taking insulin who are admitted to hospital on day of surgery

Information for all patients taking insulin who are admitted to hospital on day of surgery Information for all patients taking insulin who are admitted to hospital on day of surgery Exceptional healthcare, personally delivered Introduction Many patients are now admitted to hospital on the day

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Acute Stroke - Management of Hyperglycaemia. Contents

Acute Stroke - Management of Hyperglycaemia. Contents Acute Stroke - Management of Hyperglycaemia Classification: Policy Lead Author: Dr Amir Ahmad Additional author(s): Dr Jouher Kallingal, Professor Bob Young, Professor Pippa Tyrrell Authors Division: :

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart)

GUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart) GUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart) This guidance does not override the individual responsibility of health professionals

More information

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline Document Control Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline Author Directorate Version Author s job title Consultant Paediatrician Department

More information

Vinaya Simha, M.D. Assistant Professor, Division of Endocrinology

Vinaya Simha, M.D. Assistant Professor, Division of Endocrinology Vinaya Simha, M.D. Assistant Professor, Division of Endocrinology Faculty photo will be placed here Simha.aj@mayo.edu 2015 MFMER 3543652-1 Diabetic Ketoacidosis a few pearls Mayo School of Continuous Professional

More information

Diabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives

Diabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives Diabetic Emergencies DKA, HHS, Hypoglycemia October 2018 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Disclosure Michael McDermott has no conflict

More information

DKA Adult ICU Powerplan

DKA Adult ICU Powerplan DKA Adult ICU Powerplan Key Points for ED to ICU DKA power plan In addition to NS fluids and maintenance the regular insulin drip will either already be infusing from ED or needs to be initiated. Regular

More information

Drugs used in Diabetes. Dr Andrew Smith

Drugs used in Diabetes. Dr Andrew Smith Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin

More information

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Contact Details Name: Hospital Telephone: This protocol has 5 pages ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Please read carefully. Meticulous treatment is very important as there

More information

Case TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air

Case TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air Mr N is a 64year old Chinese gentleman who is a heavy drinker, still actively drinking, and chronic smoker of >40pack year history. He has a past medical history significant for Hypertension, Hyperlipidemia,

More information

GUIDELINES FOR THE MANAGEMENT OF DIABETES IN PALLIATIVE CARE

GUIDELINES FOR THE MANAGEMENT OF DIABETES IN PALLIATIVE CARE GUIDELINES FOR THE MANAGEMENT OF DIABETES IN PALLIATIVE CARE 16.1 GENERAL PRINCIPLES Diabetes occurs more frequently in palliative care patients than the general population. 1 Patients with pancreatic

More information

Agenda. Indications Different insulin preparations Insulin initiation Insulin intensification

Agenda. Indications Different insulin preparations Insulin initiation Insulin intensification Insulin Therapy F. Hosseinpanah Obesity Research Center Research Institute for Endocrine sciences Shahid Beheshti University of Medical Sciences November 11, 2017 Agenda Indications Different insulin preparations

More information

DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:

DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 1 DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 2 Learning Outcomes All nurses, regardless of practice setting, are required to work collaboratively with the person

More information

Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS

Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State Adam Bursua, Pharm.D., BCPS Objectives Describe the epidemiology of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar

More information

Hyperglycaemic Emergencies GRI EDUCATION

Hyperglycaemic Emergencies GRI EDUCATION Hyperglycaemic Emergencies GRI EDUCATION LEARNING OUTCOMES Develop and describe your system of blood gas interpretation and recognise common patterns of acid-base abnormality. Describe the pathophysiology

More information

Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital

Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Initiating Injectables in Type 2 Diabetes Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Increasing levels in delivery of diabetes care Complex Care support 3 3.1 People with diabetes

More information

Case Study: Competitive exercise

Case Study: Competitive exercise Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia

More information

How they work and when to take them. Diabetes Medications

How they work and when to take them. Diabetes Medications How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight

More information

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System Critical Care Guideline Two Bag System Inclusion Criteria (Definition of DKA): Blood glucose (BG) > 200 mg/dl Acidosis (bicarbonate < 15 or blood gas ph < 7.3) Associated glycosuria, ketonuria &/or ketonemia

More information

Pediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set

Pediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set Admitting MRP: Pediatrics: Dr. / Dr. on call to cover until 08:00 am Service: Medicine Team 1 Medicine Team 2 Medical subspecialty Diagnosis: Diabetic Ketoacidosis (DKA) Estimated length of stay Less than

More information

THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN

THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN Worcestershire Trusts Please attach patient sticker here or record: GP Name: Consultant:. Ward: THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN This Care Pathway

More information

Managing diabetes if you are having a colonoscopy

Managing diabetes if you are having a colonoscopy Managing diabetes if you are having a colonoscopy Diabetes and Endocrinology Patient Information Leaflet Introduction This leaflet provides advice and instructions to people with diabetes who are going

More information

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Diabetes Emergency Caesarean section or other unplanned surgery (GL822) Diabetes Emergency Caesarean section or other unplanned surgery (GL822) i.e. insulin dependent diabetic having unplanned surgery e.g. a diabetic woman with pre-labour SROM prior to elective Caesarean section.

More information

Insulin Initiation, titration & Insulin switch in the Primary Care-KISS

Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Rotorua GP CME 9 June 2012 Dr Kingsley Nirmalaraj FRACP Endocrinologist, BOPDHB & Suite 9, Promed House, Tenth Ave, Tauranga Linda

More information

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1 DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1 QUESTION # 1 7 year old boy comes to the ER with a 2 week history of abdominal pain and weight loss. Further history reveals polyuria and polydipsia,

More information

Inpatient Diabetes Care

Inpatient Diabetes Care Inpatient Diabetes Care Data from the National Diabetes Inpatient Audit suggest that the number of hospital inpatients with diabetes ranges from ~10% to over 30%. This does not mean that up to 1 in 3 inpatients

More information

Starting Insulin in General Practice

Starting Insulin in General Practice Starting Insulin in General Practice Timothy Kenealy GP & Assoc Prof of Integrated Care, University of Auckland Auckland DHB / my version + Counties DHB version Starting Insulin surprisingly simple, safe

More information

Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4

Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Page 1 of 27 Abbreviation Meaning PDSN DKA BG SC IV RCHT HDU PEWS Paediatric

More information

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,

More information

Nothing to disclose. Disclosure

Nothing to disclose. Disclosure Nothing to disclose. Disclosure Inpatient Management of Diabetes Mellitus Cindy Chin, MD Pediatrics in the Red Rocks 2015 Objectives Name 3 diagnostic criteria for diabetes mellitus. Understand and apply

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS

More information

When and how to start insulin therapy in type 2 diabetes

When and how to start insulin therapy in type 2 diabetes When and how to start insulin therapy in type 2 diabetes Anne Kilvert MD, FRCP Most patients with type 2 diabetes will eventually require insulin due to the progressive decline in betacell function. Dr

More information

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK GLP-1 agonists Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What do GLP-1 agonists do? Physiology of postprandial glucose regulation Meal ❶ ❷ Insulin Rising plasma

More information

East of England Children & Young People s (CYP) Diabetes Network

East of England Children & Young People s (CYP) Diabetes Network East of England Children & Young People s (CYP) Diabetes Network Management for Children and Young People with diabetes (>6months old 18 th birthday) during Illness Note: This version of the guideline

More information

BEST 4 Diabetes. Optimisation of insulin module

BEST 4 Diabetes. Optimisation of insulin module BEST 4 Diabetes Optimisation of insulin module Confidence and competence Where would you rate yourself? Why do all of our patient not achieve optimal blood glucose control? Insulin Therapy Goals and Purpose

More information

Hypoglyceamia and Exercise

Hypoglyceamia and Exercise Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and

More information

Management of adults with diabetes undergoing surgery and elective procedures: improving standards

Management of adults with diabetes undergoing surgery and elective procedures: improving standards Surgical outpatients Hospital admission Theatre and recovery Discharge Primary care referral Pre-operative assessment Post-operative care Management of adults with diabetes undergoing surgery and elective

More information

Four is the Floor Symptoms can be felt at higher levels if control is poor Worth confirmation using BG meter if at all possible

Four is the Floor Symptoms can be felt at higher levels if control is poor Worth confirmation using BG meter if at all possible Sandra Coats Diabetes Specialist Nurse 1 Hypoglycaemia Hyperglycaemia Diabetes and Illness sick day Diabetic Ketoacidosis HONK/HHS 2 What is Hypoglycaemia BG levels below 4mmol/l. Four is the Floor Floor

More information

There have been important changes in diabetes care which may not be covered in undergraduate textbooks.

There have been important changes in diabetes care which may not be covered in undergraduate textbooks. Diabetes Clinical update There have been important changes in diabetes care which may not be covered in undergraduate textbooks. Changes in the diagnosis of diabetes a) HbA1C Since 2011, World Health Organisation

More information

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes

More information

Brief summary of the NICE guidelines December 2013

Brief summary of the NICE guidelines December 2013 Brief summary of the NICE guidelines December 2013 Intravenous fluid therapy in adults in hospital the relevance to Emergency Department Care Applicable to patients 16 years and older receiving i.v. fluids

More information

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with

More information